Michelle Y. Zou, Robert E. Cohen, Brendon L. Ursomanno, & Lisa M. Yerke. (2023). Use of Systemic Steroids, Hormone Replacement Therapy, or Oral Contraceptives Is Associated with Decreased Implant Survival in Women. MDPI AG.
Chicago Style (17th ed.) CitationMichelle Y. Zou, Robert E. Cohen, Brendon L. Ursomanno, and Lisa M. Yerke. Use of Systemic Steroids, Hormone Replacement Therapy, or Oral Contraceptives Is Associated with Decreased Implant Survival in Women. MDPI AG, 2023.
MLA (9th ed.) CitationMichelle Y. Zou, et al. Use of Systemic Steroids, Hormone Replacement Therapy, or Oral Contraceptives Is Associated with Decreased Implant Survival in Women. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.